elranatamab
pfizer
['elranatamab', 'pivotal', 'magnetismm-3', 'multiple myeloma', 'pfizer', '$pfe']
$pfe pfizer pfizer presents first data from planned interim analysis of pivotal phase 2 magnetismm-3 trial of bcma-cd3 bispecific antibody elranatamab under investigation for relapsed/refractory multiple myeloma abstract 